New Delhi [India], May 26 (ANI): Health Ministry of India has written to the World Health Organisation (WHO) after the global health body announced to temporarily suspend the clinical trials of Hydroxychloroquine (HCQ) for the treatment of COVID-19 patients, sources told ANI.
New Delhi [India], May 26 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences (AIIMS), New Delhi, on Tuesday said that 'judicious, and appropriate' use of hydroxychloroquine (HCQ) as a standalone drug should not pose any health risks in COVID-19 cases.
Beijing [China], May 23 (ANI): Days after US drugmaker Moderna announced Phase one trial of its COVID-19 vaccine has shown positive results, researchers on Friday reported that a vaccine developed in China appears to be safe and may protect people from the deadly virus.
New Delhi [India] May 22 (ANI): The Cycle Federation of India (CFI) has called a 15-year-old girl, who cycled 1200 km over a period of seven days, for trials.
New Delhi [India], May 21 (ANI): Three drug trials to combat COVID-19 have started and seven are in the process, said Council of Scientific and Industrial Research (CSIR) Director-General (DG) Dr Shekhar C Mande on Thursday.
Washington D.C. [US], May 19 (ANI): As the scientists across the world are struggling to develop a vaccine for combating coronavirus, US drugmaker Moderna announced on Monday (local time) that the phase I trial of its Covid-19 vaccine has shown positive early results.
Washington D.C. [USA], May 17 (ANI): Clinical trials of the anti-malarial drug or hydroxychloroquine, which gained prominence overnight after being promoted by US President Donald Trump as a 'game changer' in the fight against Covid-19, have been significantly linked to cardiac problems and
New Delhi [India], May 13 (ANI): The AYUSH Ministry and the Council of Scientific and Industrial Research (CSIR) are working together on validating four Ayush formulations against COVID-19 and the trials will start within one week.
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so.
Karachi [Pakistan], May 11 (ANI): Pakistan's top hematologist said that three hospitals in the country have started clinical trials for passive immunisation with the support of National Institute of Blood Disease (NIBD) to treat the Covid-19 patients
New Delhi [India], May 9 (ANI): At least five hospitals across the country have been selected to conduct the randomised controlled clinical trials under the umbrella of World Health Organization (WHO) Solidarity trial to find an effective COVID-19 treatment.